Results 21 to 30 of about 1,302,625 (339)

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review

open access: yesHuman Vaccines & Immunotherapeutics, 2022
With the relatively rapid development of the COVID-19 pandemic, vaccine development has become crucial for limiting disease transmission. The accelerated growth in the approved COVID-19 vaccines has sparked concerns about their efficacies which have been
Ibrahim Mohammed   +13 more
semanticscholar   +1 more source

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors

open access: yesEMBO Molecular Medicine, 2021
Respiratory syncytial virus (RSV) is the leading cause of death from lower respiratory tract infection in infants and children, and is responsible for considerable morbidity and mortality in older adults. Vaccines for pregnant women and elderly which are
Emanuele Andreano   +14 more
doaj   +1 more source

Next-Generation TB Vaccines: Progress, Challenges, and Prospects

open access: yesVaccines, 2023
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global infectious disease and a leading cause of mortality worldwide. Currently, the only available vaccine for TB prevention is Bacillus Calmette–Guérin (BCG).
Zhuang Li   +4 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Vaccines in 2016

open access: yesVaccines, 2017
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Vaccines Editorial Office
doaj   +1 more source

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen

open access: yesnpj Vaccines, 2023
Seasonal influenza vaccines must be updated annually and suboptimally protect against strains mismatched to the selected vaccine strains. We previously developed a subunit vaccine antigen consisting of a stabilized trimeric influenza A group 1 ...
Maarten Swart   +21 more
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2014

open access: yesVaccines, 2015
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Vaccines Editorial Office
doaj   +1 more source

Nanomaterial Delivery Systems for mRNA Vaccines

open access: yesVaccines, 2021
The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as ...
M. Buschmann   +5 more
semanticscholar   +1 more source

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

open access: yesNature Reviews Clinical Oncology, 2021
Within the past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the development and regulatory approval of various immune-checkpoint inhibitors and chimeric antigen receptor T cell therapies in diverse indications.
Eryn Blass, P. Ott
semanticscholar   +1 more source

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Although effective vaccines against COVID-19 have been developed, additional vaccines are still needed. Objective To evaluate the efficacy and adverse events of 2 inactivated COVID-19 vaccines.
N. A. Al Kaabi   +40 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy